TNGX - Tango Therapeutics GAAP EPS of -$0.32 beats by $0.03 revenue of $5.77M misses by $1M May, 09 2023 08:54 AM Tango Therapeutics Inc. 2023-05-09 08:54:19 ET Tango Therapeutics press release ( NASDAQ: TNGX ): Q1 GAAP EPS of -$0.32 beats by $0.03 . Revenue of $5.77M (+0.2% Y/Y) misses by $1M . For further details see: Tango Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $5.77M misses by $1M